Intravenous administration of follistatin: Delivery to the liver and effect on liver regeneration after partial hepatectomy

Hepatology

Volumn 24, Issue 2, 1996, Pages 361-366

  Kogure, Kimitaka ^a   Zhang, You Qing ^b   Kanzaki, Makoto ^b   Omata, Waka ^b   Mine, Tetsuya ^c   Kojima, Itaru ^b  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FOLLISTATIN; IODINE 125; RECOMBINANT FOLLISTATIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA CONTENT; DRUG ACCUMULATION; DRUG HALF LIFE; INTRAVENOUS DRUG ADMINISTRATION; LIVER REGENERATION; MALE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RADIOACTIVITY; RAT; TISSUE DISTRIBUTION;

EID: 0029759331     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008690405     Document Type: Article

References (18)

1. LaBrecque D. Liver regeneration: a picture emerges from the puzzle. Am J Gastroenterol 1994;89:S86-S96.
2. Farivar M, Wands JR, Isselbacher KJ. Effect of insulin and glucagon on fulminant murine hepatitis. N Engl J Med 1976;295:1517-1519.
3. Baker AI, Jaspan JB, Haines NW. A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis. Gastroenterology 1981;80:1410-1414.
4. Jaspan JB, Landan RL, Schneider J. Insulin and glucagon infusion in the treatment of liver failure. Arch Intern Med 1984;144:2075-2078.
5. Harrison PM, Hughes RD, Forbes A. Failure of insulin and glucagon infusion to stimulate liver regeneration in fulminant hepatic failure. J Hepatol 1990;10:332-336.
6. Michalopoulos GK. Liver regeneration: molecular mechanisms of growth control. FASEB J 1990;4:176-187.
7. Ishiki Y, Ohnishi H, Muto Y, Matsumoto N, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotropic factor for liver regeneration and has a potent antihepatitis effect in vivo. HEPATOLOGY 1992;16:1227-1235.
8. Ying SY. Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 1988;9:267-293.
9. DePaolo LV, Bicsak TA, Ericson GF, Shimasaki S, Ling N. Follistatin and activin: a potential intrinsic regulatory system within diverse tissues. Proc Soc Exp Biol Med 1991;198:500-512.
10. Yasuda H, Mine T, Shibata H, Eto Y, Hasegawa Y, Takeuchi T, Asano S, et al. Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J Clin Invest 1993;92:1491-1496.
11. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H. Activin-binding protein from ovary is follistatin. Science 1990;247:836-838.
12. Farnworth UM, Findlay JK. Follistatin: more than follicle-stimulating hormone suppressing proteins. Mol Cell Endocrinol 1993;91:1-11.
13. Kogure K, Omata W, Kanzaki M, Zhang YQ, Yasuda H, Mine T, Kojima I. A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats. Gastroenterology 1995;108:1136-1142.
14. Higgins GM, Anderson RM. Experimental pathology of the liver. Arch Pathol 1931;12:186-202.
15. Fishback FC. A morphologic study of regeneration of the liver after partial removal. Arch Pathol 1929;7:956-977.
16. 4. Anal Biochem 1966;15:31-39.
17. Hinegardner TT. An improved fluorometric assay for DNA. Anal Biochem 1971;39:197-201.
18. Nakamura T, Sugino K, Titani K, Sugino H. Follistatin, an activin-binding protein, associates with heparan sulfate chains of proteoglycans on follicular granulosa cells. J Biol Chem 1991;266:19432-19437.